Regeneron Pharmaceuticals, Inc. (REGN)

Acerca de Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.

Al 3 de noviembre de 2026, la acción de Regeneron Pharmaceuticals, Inc. (REGN) subió a $970.11, un alza de 0.92% (+$8.85) frente al cierre anterior. En la sesión, las acciones han operado entre $953.00 y $974.34. Eso ubica a REGN cerca del máximo de su rango de 52 semanas, de $591.52 a $974.34. Regeneron Pharmaceuticals, Inc. opera en el sector de pharmaceutical preparations y tiene una capitalización de mercado de aproximadamente $95.99 mil millones, con cerca de 486.2 mil acciones negociadas.

Últimas noticias de REGN

• Regeneron Announces Investor Conference PresentationsYahoo Finance· 2 nov, 4:05 p.m. ET
• REGN Q3 deep dive: pipeline progress and core brands drive outperformanceYahoo Finance· 2 nov, 2:33 p.m. ET
• Regeneron's 'Strong Commercial' Q3 Underscores Core Business Health, RBC Capital Markets SaysYahoo Finance· 2 nov, 11:40 a.m. ET
• Should You Buy The Dip In Alnylam Stock?trefis.com· 2 nov, 9:39 a.m. ET
• Earnings roundup: AstraZeneca’s cost cuts, Alnylam’s slump and Regeneron’s resiliencebiopharmadive.com· 2 nov, 9:00 a.m. ET
• The top 5 analyst questions from Regeneron’s Q3 earnings callYahoo Finance· 2 nov, 8:49 a.m. ET
• US Stock Market Today: S&P 500 Futures Edge Higher On ISM Manufacturing TestYahoo Finance· 2 nov, 8:05 a.m. ET
• FDA Decision Watch: Regeneron And Roche’s Autoimmune Drugs, Capricor’s DMD Therapy In Spotlightstocktwits.com· 2 nov, 5:36 a.m. ET

Fuente: Yahoo Finance RSS · Actualizado el 3 de noviembre de 2026

¿Quieres titulares, alertas e investigación con IA de REGN en un solo lugar? Crea una cuenta gratis →

• $REGN back to regular scheduled programming.

  @SilverEagle· 3 nov, 11:55 a.m. ET· Alcista

• $REGN DARK POOL TRADE ALERT - LONG SHARES AND CALLS.. Bullish and Bearish Pressure Dark Pools.. As you can see , AI dominates the bearish side. HAPPY TRADING! $QQQ $AAL $V $COST

  @GlobalTradersAcademy· 3 nov, 11:01 a.m. ET· Alcista

• $ABCL $MRNA $REGN $SLS $PFE $ABCL 🧬 13 Dollar Resistance 13 dollars is in sight. But this guy won't open the door without a fight. 😂 No matter how many times you knock, it slams the brakes at $13.18 every time. Now what we need isn't the chart—it's a reason to br…

  @Stocktradesmoon· 3 nov, 10:22 a.m. ET· Alcista

• $ABCL $MRNA $REGN $SLS $LLY VERY BULLISH…ABcellera 🔥 🔥!!! 👀

  @Stocktradesmoon· 3 nov, 9:51 a.m. ET· Alcista

• $ABCL $MRNA $REGN $SLS $JNJ Now everyone is finding themselves chasing… All those sellers are now buying it up. Earnings coming up in a few days …November 9th Follow by 2 huge biotech conferences that they will be presenting at. November 9: Q3 earnings and pipeline update. Nov…

  @Stocktradesmoon· 3 nov, 9:41 a.m. ET· Alcista

Fuente: Stocktwits. Las publicaciones de usuarios son opiniones, no hechos verificados. Ver lo que es tendencia →